definiens: shall mean, with respect to a Proposed Antigen orCollaboration Antigen ( irrespective of whether such Collaboration Antigen becomes a Discontinued Antigen or a FailedAntigen ), collectively, ( a ) such Antigen ; ( b ) Antibody Equivalents that bind to and are directed against such Antigen;(c ) amino acid sequences of such Antigen or Antibody Equivalents ; ( d ) Genetic Material that encodes such Antigen orAntibody Equivalents ; ( e ) Antibody Cells that contain, express or secrete such Antibody Equivalents or GeneticMaterials that encode such Antibody Equivalents ; ( f ) uses of the foregoing ; and ( g ) Information specifically regardingthe foregoing ; in each case ( of clauses ( a ) through ( g ) ) that are not first conceived or generated under or in connectionwith the Research Program or Development Program for such Antigen ; provided, however, that Antigen - SpecificTechnology shall exclude Collaboration Technology, Additional Development Program Technology, DevelopmentProgram Technology, Process Technology, XenoMouse Technology and any Information from any freedom to operateanalyses conducted by AZ pursuant to Section 2.2.2(a )